Alan Fuhrman
CIK 1303521 · Chief Financial Officer · last filed 2026-05-07
Alan Fuhrman is a Chief Financial Officer who has filed 43 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for TYRA, was dated May 7, 2026. Across all open-market trades the lifetime net is −$315.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.14M
8
43
-$315.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TYRA | Chief Financial Officer | 36,164 | $26.99 | $976.1K | $152.0K | 12 | 2026-05-07 |
| SpringWorks Therapeutics, Inc. (SWTX) Delisted | Director | 0 | $46.99 | $0 | $0 | 8 | 2025-07-02 |
| ESPR | Director | 53,404 | $3.15 | $168.2K | $0 | 6 | 2024-05-24 |
| Checkmate Pharmaceuticals, Inc. (CMPI) Delisted | See Remarks | — | $10.50 | — | $0 | 3 | 2022-05-31 |
| Loxo Oncology, Inc. (LOXO) Delisted | Director | 0 | — | — | -$467.4K | 7 | 2019-02-15 |
| SYNLOGIC, INC. (MIRN) Delisted | Chief Financial Officer | — | — | — | $0 | 1 | 2016-03-14 |
| AMBIT BIOSCIENCES CORP (AMBI) Delisted | Chief Financial Officer | 0 | $0.54 | $0 | $0 | 3 | 2014-11-12 |
| ACHIEVE LIFE SCIENCES, INC. (SNUS) Delisted | Senior Vice President & CFO | — | — | — | $0 | 2 | 2008-03-20 |
Recent Filings
43 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-07 | TYRA | Grant (A) | +20,000 | $0 | EDGAR |
| 2026-03-17 | TYRA | Grant (A) | +1,376 | $12.6K | EDGAR |
| 2025-09-17 | TYRA | Grant (A) | +701 | $6.4K | EDGAR |
| 2025-08-07 | TYRA | Grant (A) | — | $0 | EDGAR |
| 2025-07-02 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Disp (D) | −24,727 | $0 | EDGAR |
| 2025-05-15 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Grant (A) | +10,060 | $0 | EDGAR |
| 2025-03-18 | TYRA | Grant (A) | +1,238 | $12.1K | EDGAR |
| 2024-11-01 | TYRA | Buy (P) | +9,500 | $152.0K | EDGAR |
| 2024-09-17 | TYRA | Grant (A) | +954 | $11.9K | EDGAR |
| 2024-08-16 | TYRA | Grant (A) | — | $0 | EDGAR |